CA
FRLN

CHI Advisors’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

CHI Advisors’s Portfolio FRLN Stock Details FRLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$373K Buy
86,654
+64,988
+300% +$257K 0.15% 25
2023
Q2 		$55.9K Sell
21,666
-293,629
-93% -$1.16M 0.02% 26
2023
Q1 		$2.15M Sell
315,295
-5,666
-2% -$44K 0.57% 19
2022
Q4 		$2.29M Hold
320,961
– – 0.61% 17
2022
Q3 		$3.37M Sell
320,961
-3,194
-1% -$41.6K 0.91% 19
2022
Q2 		$4.23M Hold
324,155
– – 1.62% 13
2022
Q1 		$5.45M Buy
324,155
+199,062
+159% +$3.69M 2.32% 9
2021
Q4 		$3.71M Buy
125,093
+29,928
+31% +$1.22M 1.23% 16
2021
Q3 		$4.87M Buy
95,165
+3,175
+3% +$226K 1.42% 13
2021
Q2 		$11.2M Sell
91,990
-326
-0.4% -$50.7K 2.62% 11
2021
Q1 		$17M Buy
92,316
+1,578
+2% +$374K 3.41% 11
2020
Q4 		$24.9M Buy
90,738
+2,447
+3% +$615K 7% 6
2020
Q3 		$20.7M Buy
+88,291
New +$22.1M 7.35% 6

Other funds holding FRLN

SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
APC
Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return

CHI Advisors's FRLN Position: Q3 2023 in Review

CHI Advisors increased its Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) stake by 300% in Q3 2023, buying an estimated $257K and bringing the position to 86,654 shares worth $373K. The position accounts for 0.15% of the portfolio, ranked #25.

CHI Advisors first reported a position in FRLN in Q3 2020 and has held it in 13 quarters since. The position peaked at $24.9M in Q4 2020. 12 funds tracked by Wall St. Rank hold FRLN as of Q3 2023.

  • CHI Advisors held 86,654 shares of Freeline Therapeutics Holdings plc American Depositary Shares worth $373K as of Q3 2023.
  • CHI Advisors bought 64,988 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q3 2023, an estimated $257K.
  • Freeline Therapeutics Holdings plc American Depositary Shares made up 0.15% of CHI Advisors's portfolio in Q3 2023, its #25 holding.
  • CHI Advisors first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2020 and has held it in 13 quarters since.
  • CHI Advisors's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $24.9M in Q4 2020.
  • 12 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q3 2023.

Based on CHI Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.